Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SBC Medical Group HoldingsSBC +4.08%21 EV-to-EBITDA is 2.94 as of Jul. 27, 2026, which is 33% below its 10-year median of 4.38. GuruFocus rates SBC with a GF Score™ of 21/100. The stock has 3 warning signs investors should review. Among 904 Business Services companies, SBC Medical Group Holdings ranks better than 87.28% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, SBC Medical Group Holdings's enterprise value is $213.2 Mil.
SBC Medical Group Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $72.5 Mil. Therefore, SBC Medical Group Holdings's EV-to-EBITDA for today is 2.94.
The historical rank and industry rank for SBC Medical Group Holdings's EV-to-EBITDA or its related term are showing as below:
SBC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.49 Med: 4.38 Max: 9.37
Current: 2.94
During the past 4 years, the highest EV-to-EBITDA of SBC Medical Group Holdings was 9.37. The lowest was 2.49. And the median was 4.38.
SBC's EV-to-EBITDA is ranked better than 87.28% of 904
companies
in the Business Services industry
Industry Median: 7.73
vs SBC: 2.94
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
SBC Medical Group Holdings (NAS:SBC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SBC Medical Group Holdings's PE Ratio (TTM) for today is calculated as:
SBC Medical Group Holdings's share price for today is $3.06.
SBC Medical Group Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.390.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Consulting Services subindustry, SBC Medical Group Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SBC Medical Group Holdings EV-to-EBITDA vs Business Services Industry
For the Business Services industry and Industrials sector, SBC Medical Group Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where SBC Medical Group Holdings's EV-to-EBITDA falls into.
SBC Medical Group Holdings's current Enterprise Value is $213.2 Mil.
SBC Medical Group Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $72.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SBC Medical Group Holdings (SBC) has a EV-to-EBITDA of 2.94 as of Jul. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SBC Medical Group Holdings. This is 33% below median its historical median of 4.38. Over the past decade, SBC Medical Group Holdings' EV-to-EBITDA has ranged from 2.49 to 9.37. According to the industry distribution chart, SBC Medical Group Holdings ranks #115 out of 904 companies in the Business Services industry, placing it in the top 12.7%.
Is SBC Medical Group Holdings' EV-to-EBITDA too high?
SBC Medical Group Holdings' current EV-to-EBITDA of 2.94 is 33% below median its 10-year median of 4.38. Over the past 10 years, this metric has ranged from a low of 2.49 to a high of 9.37. The Business Services industry median EV-to-EBITDA is 7.73. SBC Medical Group Holdings' value of 2.94 is 62% below this industry median. Based on the distribution chart, SBC Medical Group Holdings ranks #115 out of 904 companies in the Business Services industry, which is in the top quartile — a strong position relative to peers. Overall, SBC Medical Group Holdings has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does SBC Medical Group Holdings' EV-to-EBITDA compare to FORR and GLAI?
According to the Business Services industry distribution chart, SBC Medical Group Holdings ranks #115 out of 904 companies for EV-to-EBITDA. This places SBC Medical Group Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 7.73. SBC Medical Group Holdings' value of 2.94 is 62% below this benchmark. Historically, SBC Medical Group Holdings' own EV-to-EBITDA has ranged from 2.49 to 9.37 over the past decade. While the company's 10-year median is 4.38 vs. the industry median of 7.73, SBC Medical Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Business Services company?
The median EV-to-EBITDA among Business Services companies is 7.73, based on 904 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SBC Medical Group Holdings's current EV-to-EBITDA of 2.94 is 62% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SBC Medical Group Holdings. For the Business Services industry, the median EV-to-EBITDA is 7.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SBC Medical Group Holdings's current EV-to-EBITDA is 2.94, which is 33% below median its own 10-year median of 4.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SBC Medical Group Holdings stock overvalued right now?
SBC Medical Group Holdings (SBC) has a current EV-to-EBITDA of 2.94. The current EV-to-EBITDA is 2.94, which is 33% below median its 10-year median of 4.38 and 62% below the Business Services industry median of 7.73. SBC Medical Group Holdings' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For SBC Medical Group Holdings (SBC), the current EV-to-EBITDA is 2.94 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). The firm generates revenue mostly from these management services.
21GF Score
Get the complete analysis for SBC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBC has been successfully added to your 
